Back to Search
Start Over
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
- Source :
- PLoS ONE, PLOS ONE, PLoS ONE, Vol 11, Iss 3, p e0151703 (2016), PLoS One, Vol. 11, no. 3, p. e0151703 [1-20] (2016)
- Publication Year :
- 2015
-
Abstract
- Background: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reductions or discontinuations (sr-RD) and their impact on sustained virologic response (SVR) in patients receiving peginterferon alfa/ribavirin in routine practice. Methods: A total of 3181 HCV-mono-infected treatment-naive patients were assigned to 24 or 48 weeks of peginterferon alfa/ribavirin by their physician. Patients were categorized by time-to-first sr-RD (Week 4/12). Detailed analyses of the impact of sr-RD on SVR24 (HCV RNA
- Subjects :
- Genetics and Molecular Biology (all)
Male
Chronic Hepatitis
Hepacivirus
Ribavirin/adverse effects
Asthenia/chemically induced
Polyethylene Glycol
Biochemistry
Polyethylene Glycols
Body Mass Index
Chronic Liver Disease
0302 clinical medicine
Neutropenia/chemically induced
Interferon-alpha/adverse effects
Medicine
Chronic
lcsh:Science
Liver Diseases
virus diseases
Antiviral Agents/adverse effects
Cohort
Science & Technology - Other Topics
030211 gastroenterology & hepatology
Drug Therapy, Combination
Cohort study
Human
medicine.medical_specialty
Alpha interferon
Gastroenterology and Hepatology
Antiviral Agents
Microbiology
Dose-Response Relationship
03 medical and health sciences
Pharmacotherapy
Hepatitis C, Chronic/drug therapy
Dose Prediction Methods
Drug Therapy
Anemia/chemically induced
Humans
Hemoglobin
Aged
Medicine and health sciences
Biochemistry, Genetics and Molecular Biology (all)
Hepaciviru
Science & Technology
Dose-Response Relationship, Drug
Flaviviruses
lcsh:R
Organisms
Biology and Life Sciences
Proteins
medicine.disease
digestive system diseases
chemistry
Agricultural and Biological Sciences (all)
Withholding Treatment
Asthenia
Immunology
Proportional Hazards Model
lcsh:Q
Human medicine
RNA viruses
Physiology
lcsh:Medicine
Peginterferon-alfa
Polyethylene Glycols/adverse effects
Adult
Anemia
Cohort Studies
Female
Hepatitis C, Chronic
Host-Pathogen Interactions
Interferon-alpha
Middle Aged
Neutropenia
Outcome Assessment (Health Care)
Proportional Hazards Models
RNA, Viral
Recombinant Proteins
Ribavirin
Medicine (all)
chemistry.chemical_compound
Outcome Assessment, Health Care
Medicine and Health Sciences
030212 general & internal medicine
Viral
Pathology and laboratory medicine
Multidisciplinary
biology
Hepatitis C virus
Pharmaceutics
Hepatitis C
Hematology
Recombinant Protein
Outcome Assessment (Health Care)/methods
Medical microbiology
Host-Pathogen Interaction
Multidisciplinary Sciences
Physiological Parameters
Research Design
Combination
Viruses
Drug
Pathogens
Host-Pathogen Interactions/drug effects
Research Article
Clinical Research Design
Research and Analysis Methods
Internal medicine
Recombinant Proteins/adverse effects
RNA, Viral/blood
Antiviral Agent
business.industry
Body Weight
Hepacivirus/drug effects
Viral pathogens
biology.organism_classification
Hepatitis viruses
Microbial pathogens
RNA
Adverse Events
Cohort Studie
business
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 11
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- PloS one
- Accession number :
- edsair.doi.dedup.....0aa232bd60ef5b9e1f5fc68dc781a16d